购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

Anti-B7-1 Antibody (4I630)

Rating icon 还可以
产品编号 TMAY-01080

Anti-B7-1 Antibody (4I630) 是一种 Mouse 抗体,靶向 B7-1。Anti-B7-1 Antibody (4I630) 可用于 ELISA,FCM。

Anti-B7-1 Antibody (4I630)

Anti-B7-1 Antibody (4I630)

Rating icon 还可以
产品编号 TMAY-01080

Anti-B7-1 Antibody (4I630) 是一种 Mouse 抗体,靶向 B7-1。Anti-B7-1 Antibody (4I630) 可用于 ELISA,FCM。

TargetMol
产品信息正在更新中,如果您想购买,请点击大包装&定制按钮.
大包装 & 定制
实验操作小课堂
常见问题解答
查看更多
联系我们获取更多批次信息
资源下载

产品介绍

生物活性
产品描述
Anti-B7-1 Antibody (4I630) is a Mouse antibody targeting B7-1. Anti-B7-1 Antibody (4I630) can be used in ELISA,FCM.
Ig Type
Monoclonal Mouse IgG1
克隆号
4I630
交叉反应
Human
验证活性
Flow cytometric analysis of Human B7-1(CD80) expression on Daudi cells. Cells were stained with purified anti-Human B7-1(CD80), then a FITC-conjugated second step antibody. The histogram were derived from gated events with the forward and side light-scatter characteristics of intact cells.
应用
ELISA,FCM
推荐剂量
ELISA: 1:1000-1:2000; FCM: 1:25-1:100
抗体种类
Monoclonal
宿主来源Mouse
构建方式This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CD80 / B7-1 (rh CD80 / B7-1; TMPY-01063; Met 1-Asn 242; NP_005182.1). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
纯化方式Protein A
性状Liquid
缓冲液0.2 μm filtered solution in PBS
研究背景The B-lymphocyte activation antigen B7-1 (referred to as B7), also known as CD80, is a member of cell surface immunoglobulin superfamily and is expressed on the surface of antigen-presenting cells including activated B cells, macrophages and dendritic cells. As costimulatory ligands, B7-1 which exists predominantly as dimer and the related protein B7-2, interact with the costimulatory receptors CD28 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) expressed on T cells, and thus constitute one of the dominant pathways that regulate T cell activation and tolerance, cytokine production, and the generation of CTL. The B7/CD28/CTLA4 pathway has the ability to both positively and negatively regulate immune responses. CD80 is thus regarded as promising therapeutic targets for autoimmune diseases and various carcinomas.Cancer ImmunotherapyCo-inhibitory Immune Checkpoint TargetsImmune CheckpointImmune Checkpoint Detection: AntibodiesImmune Checkpoint Detection: ELISA AntibodiesImmune Checkpoint Detection: FCM AntibodiesImmune Checkpoint Detection: IHC AntibodiesImmune Checkpoint Detection: WB AntibodiesImmune Checkpoint ProteinsImmune Checkpoint TargetsImmunotherapyTargeted Therapy
偶联与修饰
偶联
Unconjugated
其他可选修饰符
Biotin/FITC/PE
可提供抗体种类
4
抗原信息
免疫原
Recombinant Human CD80 / B7-1 Protein (TMPY-01063)
抗原种属
Human
研究领域
Cancer Drug Targets
存储&运输
储存方式Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free.
运输方式Shipping with blue ice.

SCI 文献

计算器

  • 稀释 计算器

评论列表

4个月前
5.0
Rating icon 很棒

评论内容

Related Tags: buy Anti-B7-1 Antibody (4I630) | purchase Anti-B7-1 Antibody (4I630) | Anti-B7-1 Antibody (4I630) cost | order Anti-B7-1 Antibody (4I630)